Dr. Richter studied biotechnology at the TU Braunschweig and the University of Waterloo, and received his Ph.D. from the MPI for terrestrial microbiology in Marburg. While there, he focused on characterization of CRISPR-Cas systems, specifically the maturation of CRISPR RNAs. Dr. Richter completed his postdoctoral studies at the laboratories of Emmanuelle Charpentier, moving to the Helmholtz-Centre for Infection Biology and later the Max-Planck-Institute for Infection Biology. At WACKER, Dr. Richter is responsible for business development and technology scouting for innovative approaches, specifically anything related to nucleic acids. He has been a key part of growing WACKER’s nucleic acid research from scratch, including plasmid DNA and mRNA manufacturing, as well as formulation and early analysis of the functionality.